Can Stem Cell Therapy Cure Kidney Failure?
Kidneys being one
of the vital organ of our metabolic system, we cannot afford to make them
nonfunctional, due chronic kidney disorders. As we all know, in some of
the developed countries, on the go life style has forced many people to be
suffering with life threatening disorders, such as heart attack, high blood
pressure and chronic diabetes can have major impact on normal functioning of
our kidneys. In this regard,
although demand for kidney transplant is increasing across the globe, there is
still a scarcity of suitable donated organs to fulfill this growing demand.
In such scenario,
stem cell therapy can be helpful
in offering alternative therapeutic solution to people with kidney disorders. In the studies related to
further analysis of number of cells involved in kidney functioning, it has been
evident that a type of cell identified to be renal progenitor cells is
responsible for structuration of nephrons, that are primary responsible for
proper kidney functioning.
Stem cells are characterized with
their ability to differentiate into multiple tissue specific cells, including
renal progenitor cells of nephrons. Further research in the area has suggested that some of the
resident stem cells found near the area of nephrons are similar in
characteristic as that of bone marrow stem cells. In the case of diseased
condition, the number of stem cells is not sufficient to make up the number of
lost or degenerated cells. Thus, isolation of stem cells from autologous sources such
as, bone marrow and adipose tissues can be effective in restoring function of
lost nephrons, leading towards the effective cure.
Global Institute
of Stem Cell Therapy and Research can be noted as the premium institute,
facilitating stem cell research and its therapeutic applications, headquartered
in San Diego, California (USA); and is progressing at a faster pace with the vision to
provide effective solution to various degenerative diseases. We have mastered our
technology in isolating stem cells from autologous tissue sources, enriching
them in the laboratory and infusion back at the site of injury.
The
meaningful research on various facets of regenerative medicines that has been
carried out at GIOSTAR has indeed been documented in various
prestigious journals.
Comments
Post a Comment